CorMedix CRMD
NASDAQ CRMD
$7.70 -0.23 (-2.90%)
At close: Sep 30, 2026 · 4:00 PM EDT

CorMedix (CRMD) EV to EBIT (2025 - 2026)

Updated

CorMedix's (CRMD) EV to EBIT was 2.04 for Q2 2026, down 86.2% from 14.77 a year earlier.

Analysis

CorMedix (CRMD) EV to EBIT (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, CorMedix's EV to EBIT came in at -0.25; for FY2025, it came in at 4.00.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 CorMedix 615.90 Mn -36.62 Mn 77.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.04
Dec 31, 2025 5.08
Sep 30, 2025 8.22
Jun 30, 2025 14.77
Mar 31, 2025 23.46
API Access

CorMedix EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=CRMD&period=max&api_key=YOUR_API_KEY